Iranian Journal of War and Public Health

eISSN (English): 2980-969X
eISSN (Persian): 2008-2630
pISSN (Persian): 2008-2622
Volume 14, Issue 2 (2022)                   Iran J War Public Health 2022, 14(2): 211-216 | Back to browse issues page

Print XML PDF HTML Full-Text (HTML)


How to cite this article
Abdullah A, Eltayef E, Khamis W. Comparison of Levels of Vitamin D, Vitamin D Receptor and Vitamin D Binding Protein in Women with Osteoporosis and Osteopenia. Iran J War Public Health 2022; 14 (2) :211-216
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rights and permissions
1- Department of Chemistry, College of Science, University of Al Mustansiriyah, Baghdad, Iraq
* Corresponding Author Address: (
Abstract   (748 Views)
Aims: Osteopenia describes a decrease in bone mineral density below normal reference values, yet not low enough to meet the diagnostic criteria for osteoporosis. The aim of this study was to compare the levels of vitamin D, vitamin D receptor and vitamin D binding protein in women with osteoporosis and osteopenia.
Instruments & Methods: This descriptive study was conducted on 110 postmenopausal women aged 52 to 73 years who referred to Baghdad Medical City Hospital from January 2021 to October 2021. Subjects were divided into three groups based on T-score results: control, osteopenia, and osteoporosis. Blood samples were collected from each participant to assess biochemical tests and dual energy X-ray absorptiometry used to diagnose osteoporosis.
Findings: There was no significant difference in vitamin D and vitamin D receptor levels between the groups (p>0.05). Vitamin D binding protein level in healthy group was significantly higher than osteoporosis group (p=0.005), and DBP level in osteopenia was significantly higher than osteoporosis (p=0.001), but there was no significant difference between healthy and osteopenia groups (p=0.53). Differences between groups were significant in terms of bone mineral density (p<0.001).
Conclusion: Comparison of levels of vitamin D, vitamin D receptor, and vitamin D-binding protein among women with osteoporosis and osteopenia, despite differences between the two groups in bone mineral density, does not show a significant difference.

1. Hou Y-C, Wu C-C, Liao M-T, Shyu J-F, Hung C-F, Yen T-H, et al. Role of nutritional vitamin D in osteoporosis treatment. Clin Chim Acta. 2018;484:179-91. [Link] [DOI:10.1016/j.cca.2018.05.035]
2. Blackie R. Diagnosis, assessment and management of osteoporosis. Prescriber. 2020;31(1):14-9. [Link] [DOI:10.1002/psb.1815]
3. Ferdous HS, Afsana F, Qureshi NK, Rouf RSB. Osteoporosis: A review. Birdem Med J. 2015;5(1):30-6. [Link] [DOI:10.3329/birdem.v5i1.28371]
4. Laird E, Ward M, McSorley E, Strain JJ, Wallace J. Vitamin D and bone health; Potential mechanisms. Nutrients. 2010;2(7):693-724. [Link] [DOI:10.3390/nu2070693]
5. Sun J. Dietary vitamin D, vitamin D receptor, and microbiome. Curr Opin Clin Nutr Metab Care. 2018;21(6):471-4. [Link] [DOI:10.1097/MCO.0000000000000516]
6. Giustina A, Adler RA, Binkley N, Bouillon R, Ebeling PR, Lazaretti-Castro M, et al. Controversies in vitamin D: summary statement from an international conference. J Clin Endocrinol Metab. 2019;104(2):234-40. [Link] [DOI:10.1210/jc.2018-01414]
7. Hanel A, Carlberg C. Vitamin D and evolution: Pharmacologic implications. Biochem Pharmacol. 2020;173:113595. [Link] [DOI:10.1016/j.bcp.2019.07.024]
8. Bikle DD. Vitamin D: Newer concepts of its metabolism and function at the basic and clinical level. J Endocrine Soc. 2020;4(2):bvz038. [Link] [DOI:10.1210/jendso/bvz038]
9. Fischer V, Haffner-Luntzer M, Amling M, Ignatius A. Calcium and vitamin D in bone fracture healing and post-traumatic bone turnover. Eur Cell Mater. 2018;35:365-85. [Link] [DOI:10.22203/eCM.v035a25]
10. Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev. 2016;96(1):365-408. [Link] [DOI:10.1152/physrev.00014.2015]
11. Alejandro P, Constantinescu F. A review of osteoporosis in the older adult: an update. Rheum Dis Clin North Am. 2018;44(3):437-51. [Link] [DOI:10.1016/j.rdc.2018.03.004]
12. Cannarella R, Barbagallo F, Condorelli RA, Aversa A, La Vignera S, Calogero AE. Osteoporosis from an endocrine perspective: the role of hormonal changes in the elderly. J Clin Med. 2019;8(10):1564. [Link] [DOI:10.3390/jcm8101564]
13. Tanaka S, Ando K, Kobayashi K, Hida T, Ito K, Tsushima M, et al. A low phase angle measured with bioelectrical impedance analysis is associated with osteoporosis and is a risk factor for osteoporosis in community-dwelling people: the Yakumo study. Arch Osteoporos. 2018;13(1):39. [Link] [DOI:10.1007/s11657-018-0450-8]
14. Zanker J, Duque G. Osteoporosis in older persons: old and new players. J Am Geriatr Soc. 2019;67(4):831-40. [Link] [DOI:10.1111/jgs.15716]
15. Hariri AF, Almatrafi MN, Zamka AB, Babaker AS, Fallatah TM, Althouwaibi OH, et al. Relationship between body mass index and T-scores of bone mineral density in the hip and spine regions among older adults with diabetes: A retrospective review. J Obes. 2019;2019:9827403. [Link] [DOI:10.1155/2019/9827403]
16. Xu H, Wang Z, Li X, Fan M, Bao C, Yang R, et al. Osteoporosis and osteopenia among patients with type 2 diabetes aged≥ 50: role of sex and clinical characteristics. J Clin Densitom. 2020;23(1):29-36. [Link] [DOI:10.1016/j.jocd.2019.04.004]
17. Kuchuk NO, Van Schoor NM, Pluijm SM, Chines A, Lips P. Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: global perspective. J Bone Miner Res. 2009;24(4):693-701. [Link] [DOI:10.1359/jbmr.081209]
18. Holick MF, Siris ES, Binkley N, Beard MK, Khan A, Katzer JT, et al. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab. 2005;90(6):3215-24. [Link] [DOI:10.1210/jc.2004-2364]
19. Cauley JA, LaCroix AZ, Wu L, Horwitz M, Danielson ME, Bauer DC, et al. Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med. 2008;149(4):242-50. [Link] [DOI:10.7326/0003-4819-149-4-200808190-00005]
20. Bhan I. Vitamin d binding protein and bone health. Int J Endocrinol. 2014;2014:561214. [Link] [DOI:10.1155/2014/561214]
21. Jorde R. The role of vitamin D binding protein, total and free 25-hydroxyvitamin D in diabetes. Front Endocrinol. 2019;10:79. [Link] [DOI:10.3389/fendo.2019.00079]
22. Martínez-Aguilar MM, Aparicio-Bautista DI, Ramírez-Salazar EG, Reyes-Grajeda JP, la Cruz-Montoya D, Aldo H, et al. Serum proteomic analysis reveals Vitamin D-Binding Protein (VDBP) as a potential biomarker for low bone mineral density in Mexican postmenopausal women. Nutrients. 2019;11(12):2853. [Link] [DOI:10.3390/nu11122853]
23. Ebeling PR, Eisman JA. Vitamin D and osteoporosis. In: Feldman D, editor. Vitamin D. 4th Edition: Elsevier; 2018. p. 203-20. [Link] [DOI:10.1016/B978-0-12-809963-6.00068-7]
24. Lim SK, Park YS, Park JM, Song YD, Lee EJ, Kim KR, et al. Lack of association between vitamin D receptor genotypes and osteoporosis in Koreans. J Clin Endocrinol Metab. 1995;80(12):3677-81. [Link] [DOI:10.1210/jcem.80.12.8530619]
25. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Ame J Med. 2004;116(9):634-9. [Link] [DOI:10.1016/j.amjmed.2003.12.029]
26. Lips P, Goldsmith D, De Jongh R. Vitamin D and osteoporosis in chronic kidney disease. J Nephrol. 2017;30(5):671-5. [Link] [DOI:10.1007/s40620-017-0430-x]
27. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med. 1992;327(23):1637-42. [Link] [DOI:10.1056/NEJM199212033272305]
28. Palmieri GM, Pitcock JA, Brown P, Karas JG, Roen LJ. Effect of calcitonin and vitamin D in osteoporosis. Calcif Tissue Int. 1989;45(3):137-41. [Link] [DOI:10.1007/BF02556055]
29. Sunyecz JA. The use of calcium and vitamin D in the management of osteoporosis. Ther Clin Risk Manag. 2008;4(4):827-36. [Link] [DOI:10.2147/TCRM.S3552]
30. Ji M-X, Yu Q. Primary osteoporosis in postmenopausal women. Chronic Dis Transl Med. 2015;1(1):9. [Link] [DOI:10.1016/j.cdtm.2015.02.006]
31. Demir B, Haberal A, Geyik P, Baskan B, Ozturkoglu E, et al. Identification of the risk factors for osteoporosis among postmenopausal women. Maturitas. 2008;60(3-4):253-6. [Link] [DOI:10.1016/j.maturitas.2008.07.011]
32. Sadat-Ali M, Al-Habdan IM, Al-Mulhim FA, El-Hassan AY. Bone mineral density among postmenopausal Saudi women. Saudi medical journal. 2004;25(1):1623-5. [Link]
33. Pouresmaeili F, Kamalidehghan B, Kamarehei M, Goh YM. A comprehensive overview on osteoporosis and its risk factors. Ther Clin Risk Manag. 2018;14:2029-49. [Link] [DOI:10.2147/TCRM.S138000]

Add your comments about this article : Your username or Email: